DiaSorin (DSRLF)
(Delayed Data from OTC)
$99.86 USD
0.00 (0.00%)
Updated Jun 27, 2024 12:43 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for DiaSorin SpA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,243 | 1,434 | 1,464 | 1,007 | 791 |
Cost Of Goods | NA | 485 | 488 | 318 | 244 |
Gross Profit | NA | 949 | 976 | 689 | 547 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 579 | 479 | 318 | 303 |
Income After Depreciation & Amortization | 0 | 370 | 496 | 370 | 244 |
Non-Operating Income | NA | -27 | -26 | 0 | -2 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | 343 | 472 | 370 | 242 |
Income Taxes | NA | 90 | -105 | 3 | 45 |
Minority Interest | NA | -1 | 0 | 83 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 173 | 253 | 577 | 367 | 197 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 173 | 254 | 368 | 284 | 197 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 532 | 610 | 440 | 310 |
Depreciation & Amortization (Cash Flow) | NA | 161 | 114 | 70 | 66 |
Income After Depreciation & Amortization | 0 | 370 | 496 | 370 | 244 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 55.75 | 57.75 | 57.12 | 55.08 | 54.71 |
Diluted EPS Before Non-Recurring Items | 4.36 | 5.79 | 7.39 | 5.14 | 3.59 |
Diluted Net EPS (GAAP) | 3.11 | 4.37 | 6.39 | 5.14 | 3.58 |
Fiscal Year end for DiaSorin SpA falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |